Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 13 studies | 40% ± 13% | |
| basal cell | 8 studies | 39% ± 21% | |
| type I pneumocyte | 7 studies | 29% ± 11% | |
| club cell | 5 studies | 35% ± 16% | |
| respiratory goblet cell | 5 studies | 39% ± 17% | |
| endothelial cell of lymphatic vessel | 5 studies | 27% ± 5% | |
| type II pneumocyte | 4 studies | 22% ± 4% | |
| epithelial cell | 3 studies | 45% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 99% | 4539.88 | 572 / 578 | 92% | 35.36 | 1068 / 1155 |
| kidney | 100% | 3973.52 | 89 / 89 | 89% | 22.17 | 802 / 901 |
| thymus | 99% | 3876.86 | 646 / 653 | 77% | 12.95 | 467 / 605 |
| breast | 70% | 2734.35 | 322 / 459 | 94% | 58.72 | 1053 / 1118 |
| prostate | 91% | 2599.08 | 224 / 245 | 55% | 5.60 | 274 / 502 |
| uterus | 62% | 849.85 | 105 / 170 | 83% | 24.72 | 383 / 459 |
| esophagus | 52% | 3072.02 | 753 / 1445 | 93% | 46.41 | 170 / 183 |
| skin | 72% | 4778.49 | 1305 / 1809 | 68% | 13.94 | 319 / 472 |
| stomach | 76% | 2005.72 | 274 / 359 | 58% | 8.97 | 167 / 286 |
| bladder | 57% | 1051.00 | 12 / 21 | 63% | 12.84 | 319 / 504 |
| ovary | 9% | 70.83 | 16 / 180 | 93% | 28.62 | 401 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 37.44 | 43 / 45 |
| spleen | 95% | 1439.70 | 230 / 241 | 0% | 0 | 0 / 0 |
| intestine | 23% | 455.60 | 221 / 966 | 69% | 9.83 | 363 / 527 |
| pancreas | 4% | 34.55 | 13 / 328 | 77% | 11.71 | 137 / 178 |
| heart | 75% | 900.25 | 650 / 861 | 0% | 0 | 0 / 0 |
| liver | 40% | 381.07 | 90 / 226 | 18% | 2.20 | 75 / 406 |
| eye | 0% | 0 | 0 / 0 | 55% | 6.89 | 44 / 80 |
| adipose | 41% | 351.52 | 488 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 1.39 | 5 / 29 |
| brain | 4% | 48.97 | 101 / 2642 | 10% | 1.07 | 67 / 705 |
| adrenal gland | 8% | 60.98 | 21 / 258 | 1% | 0.20 | 3 / 230 |
| blood vessel | 7% | 62.11 | 87 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 3% | 32.71 | 27 / 929 | 0% | 0 | 0 / 0 |
| muscle | 0% | 1.05 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0090251 | Biological process | protein localization involved in establishment of planar polarity |
| GO_0060488 | Biological process | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis |
| GO_0001764 | Biological process | neuron migration |
| GO_0045176 | Biological process | apical protein localization |
| GO_0060490 | Biological process | lateral sprouting involved in lung morphogenesis |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO_0042249 | Biological process | establishment of planar polarity of embryonic epithelium |
| GO_0001843 | Biological process | neural tube closure |
| GO_0007417 | Biological process | central nervous system development |
| GO_0048105 | Biological process | establishment of body hair planar orientation |
| GO_0007266 | Biological process | Rho protein signal transduction |
| GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
| GO_0060489 | Biological process | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
| GO_0001736 | Biological process | establishment of planar polarity |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | CELSR1 |
| Protein name | Alternative protein CELSR1 Cadherin EGF LAG seven-pass G-type receptor 1 Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2) |
| Synonyms | FMI2 CDHF9 |
| Description | FUNCTION: Receptor that may have an important role in cell/cell signaling during nervous system formation. FUNCTION: Receptor that may have an important role in cell/cell signaling during nervous system formation. . |
| Accessions | ENST00000674500.2 ENST00000454637.2 [Q9NYQ6-2] ENST00000262738.9 [Q9NYQ6-1] A0A6I8PIX5 ENST00000468025.1 A0A6I8PRV8 ENST00000674312.1 Q9NYQ6 A0A6I8PIW5 ENST00000473624.2 L8ECE5 A0A6I8PRU0 ENST00000674359.1 A0A6I8PL36 ENST00000497509.1 A0A6I8PRD4 H0Y7R9 ENST00000454637 |